Find an expert
At Birmingham Children's Hospital we are lucky to have some of top experts in their fields as part of our team.
If you are a media organisation and would like to get in touch with one of them please contact our Communications Manager, Paul Whittaker - firstname.lastname@example.org, 0121 333 8425.
- Mr David Barron - Cardiac surgery
- Dr Martin English - Oncology
- Dr Heather Duncan - Intensive care, RAPID study
- Dr Wolfgang Högler - Rare bone and growth diseases
- Dr Helen Jenkinson - Oncology
- Ms Andrea Jester - Plastic and hand reconstruction surgery
- Professor Deirdre Kelly CBE - Liver disease and transplantation
- Dr Larissa Kerecuk - Rare diseases, nephrology
- Dr David Milford - Renal transplantation
- Rev. Paul Nash - Paediatric chaplaincy, spiritual care
- Dr Tina Newton - Emergency care and trauma
- Dr Fiona Reynolds - Paediatric intensive care, Major trauma and long-term ventilation
- Michelle McLoughlin - Paediatric nursing
Expertise: Liver disease and transplantation
Professor Deirdre Kelly is an expert in the treatment of children with all forms of liver disease. An innovator, leader and revolutionary clinician, she set up Birmingham Children’s Hospital’s Liver Unit in 1989.
Under her guidance and direction it has become the county’s leading paediatric liver unit, based on the philosophy of family-centred care. Since opening, more than 930 liver transplants have been carried out by the unit, which has a worldwide reputation for quality and innovation.
Professor Kelly and her multi-disciplinary team of over 50 physicians, surgeons, nurses and health professionals have transformed survival rates from 40 percent of children surviving liver transplants for one year in 1989 to 90 percent within two years.
Her research interests include molecular genetics of inherited liver disease, the development of stem cell therapy, treatment of viral hepatitis, immunosuppression and quality of life post-transplantation. The Unit has led the way in identifying new mechanisms of disease, streamlining diagnosis and establishing new ways of treating children with liver disease.
She has been Chair or President of numerous national and international professional bodies and has developed a worldwide network, providing training for doctors and nurses to exchange knowledge, both in research and advance is practice, helping to improve treatment and survival rates for a whole generation of children.
Expertise: Hand and upper limb conditions, reconstructive hand and upper limb surgery
Ms Jester joined our plastic surgery team in 2008 after previously spending time in Germany, firstly at the Department of Plastic Surgery at the BG Trauma Clinic Ludwigshafen and then at the University Hospital of Mannheim in its Department of Paediatric Surgery.
She has been the clinical lead for the hand and upper limb service for more than five years.
Andrea’s main fields of interest are inherited and acquired conditions of the hand and upper limb in children, along with the forefoot. This includes a variety of conditions ranging from fusions or duplications of the fingers to the more complex upper limb conditions, as well as obstetric brachial plexus injuries.
She is a member of several professional bodies, including the Royal College of Surgeons, the British Association for Plastic and Reconstructive Surgery and the British Society of Surgery of the Hand. She has also researched and published widely on improving outcomes for young people who need to undergo hand and upper limb surgery.
Expertise: Paediatric chaplaincy, multi-faith chaplaincy, religious and spiritual care.
Rev. Nash has worked at Birmingham Children’s Hospital since 2002 and has been our Senior Chaplain for more than 11 years, managing a unique multi-faith team with specialisms in spiritual care with children, bereavement care and staff support.
Paul is the co-founder of the Paediatric Chaplaincy Network for Great Britain and Ireland and Director of Red Balloon Resources, which publishes in the fields of paediatric religious and spiritual care in relation to daily, palliative, end of life and bereavement care. He’s also recently launched the world’s first Centre of Paediatric Spiritual Care; a hub for research and study.
Rev. Nash, a lecturer for the Midlands Centre for Youth Ministry, is a prolific writer himself on these subjects, writing Supporting Dying Children and their Families: A Handbook for Christian Ministry, published in 2011, and co-writing Multifaith Care for Sick and Dying Children and their Families and Spiritual care with Sick children and Young People, which were both published this year. In addition he edited the 2013 publication, Working with children and young people; Good practice guidelines for Healthcare chaplains.
Expertise: Paediatric renal transplantation, paediatric hypertension and paediatric renal genetic disease.
Dr Milford, who has been a consultant Birmingham Children’s Hospital for more than 20 years, is specialist in the treatment of kidney diseases, including kidney transplantation.
David has maintained a continual research interest and has published more than 100 articles, as well as contributing to textbooks, covering the subject of paediatric nephrology.
He has held many leading positions, regionally and nationally, covering this part of medicine. In recent years, Dr Milford has developed an interest in supporting renal transplantation in the developing world and is a trustee of the charity Transplant Links Community, which supports the development of transplant services in the developing world.
David is a member of The Renal Association, British Transplant Society, as well as the European and International societies for Pediatric Nephrology.
Expertise: Treatment of brain and spinal tumours, chemotherapy treatment for children and young people, late effects of childhood cancer treatments.
Dr English is a widely respected consultant with particular expertise in the treatment and care of children with brain and spinal tumours, along with the monitoring for late effects of childhood cancer treatments in teenagers and young adults.
Martin, who joined the hospital as a Consultant Paediatric Oncologist in 2001, is our chemotherapy lead and Lead Clinician for the Neurooncology Multi-disciplinary Team.
Nationally, Dr English is a member of the Clinical Reference Group for Children’s Cancer to NHS England and is an advisor on children’s chemotherapy for the Systemic Anti-Cancer Data Set collected by the National Cancer Information Service. He’s also a member of the UK Children’s Cancer and Leukaemia Group.
Martin has supported several national research trials as a reviewer of chemotherapy schedules involving children and member of monitoring committees. In addition, he is an investigator in international trials for the treatment of ependymoma, the second most common malignant brain tumour found in children.
Expertise: Retinoblastoma and treatment of the rare form of eye cancer and long-term health effects to childhood cancer survivors.
Dr Jenkinson is a national lead in treating retinoblastoma - a rare form of cancer that affects the eyes of children, usually under the age of five. Birmingham Children’s Hospital is one of only two centres in the UK that cares for young people with the disease that develops in only 40 to 50 children around the country each year.
Helen is also our clinical lead for the Late Effects Multidisciplinary team and has a major role in the care of long-term survivors of cancer in our outpatient Oncology Clinic and the Adult Late Effects Clinic at University Hospital Birmingham.
Dr Jenkinson has a number of national roles and currently chairs the Children’s Cancer and Leukaemia Group (CCLG) Late Effects Core Discipline group and Retinoblastoma Special Interest group. She is the clinical advisor to the British Childhood Cancer Survivorship Study at the University of Birmingham and also chairs the West Midlands Regional Children’s tumour Registry a specialist children’s cancer registry covering the population of the West Midlands.
Helen, a consultant at Birmingham Children’s Hospital since 2002, also holds an active research interest and has been part of studies looking into risks of adverse health effects in those that have survived childhood cancer.
Expertise: Paediatric Intensive Care, Major Trauma and Long Term Ventilation.
Dr Reynolds joined Birmingham Children’s Hospital as a Consultant in 2002. She works in the Paediatric Intensive Care Unit looking after critically ill children and has particular expertise in children who have long-term ventilation needs. She is part of the team who provide Extracorporeal Life Support for some of the hospital’s most poorly patients needing heart and lung support.
Fiona was the clinical lead in PICU until 2010 when she became the Deputy Chief Medical Officer. In 2015 she became Chief Medical Officer, which is the professional lead for the doctors at Birmingham Children’s Hospital.
She has led a number of projects including the development of palliative care advance care plans and Birmingham Children’s Hospital’s successful bid to become a Major Trauma Centre in 2012. She currently is working with University Hospital Birmingham to develop a new paediatric electronic prescribing system. Dr Reynolds was, until recently, the Chair of the Committee who oversee Paediatric Intensive Care training in the UK.
Dr Heather Duncan, Paediatric Intensive Care Consultant and RAPID Study Lead (Real-Time Adaptive and Predictive Indicator of Deterioration)
Dr Heather Duncan completed undergraduate education in South Africa and qualified in Paediatrics and Paediatric Intensive Care in the UK, following a Fellowship in Critical Care at Toronto’s Hospital for Sick Children in 2003.
She is a full-time Paediatric Intensive Care Consultant and Paediatric Intensive Care Associate Clinical Director (clinical lead) at Birmingham Children’s Hospital - the largest single-site Paediatric Intensive Care unit in the country.
Dr Duncan has broad research interests in clinical service development, quality improvement, risk reduction and innovation in health care, although her main focus has been on developing a Paediatric Early Warning system to reduce cardiac arrest.
She is currently leading on the pioneering RAPID (Real-Time Adaptive and Predictive Indicator of Deterioration) study – the first of its type in the world.
The project, due to be completed in late 2017, is taking place at Birmingham Children’s Hospital in collaboration with McLaren Applied Technologies, Isansys Lifesciences, Aston and Birmingham Universities.
RAPID is developing adaptive models for patient-specific early warning and has introduced interesting dialogue on how healthcare can learn from motorsport and applied mathematical analysis developed in finance and environmental monitoring to detect changing patterns in patient physiology.
Expertise: Rare bone and growth diseases
Dr Högler is a Consultant Paediatric Endocrinologist and the hospital’s Endocrinology and Diabetes department head. He is also an Honorary Senior Lecturer at the University of Birmingham.
He received paediatric and endocrine training at the Medical University Innsbruck, Austria and at The Children’s Hospital at Westmead, Sydney, Australia.
His Department is one of the largest paediatric endocrine units in Europe and regularly hosts international clinical, research and ESPE fellows.
Dr Högler’s clinical research group focuses on pathophysiology and management of rare bone and growth diseases such as osteogenesis imperfecta, hypophosphatasia and rickets as well as disorders in vitamin D and growth hormone metabolism.
He chaired the 7th International Conference on Children’s Bone Health (ICCBH) and the Global Consensus for the Prevention and Management of Rickets. He also organises postgraduate paediatric endocrine seminars for the Ipokrates Foundation.
Expertise: Major trauma
Dr Tina Newton has been a consultant in the NHS for 11 years. She worked for the first seven of these this in a large University teaching hospital as a Children’s Emergency and Children’s Intensive Care Consultant.
Originally from the South East of England, she came to study medicine at Birmingham University in 1986 and has remained in the region ever since. She has a medical degree, a diploma in Heath Care Ethics and law and is a fellow of the Royal College of Paediatrics and Child Heath.
Tina is passionate about Children’s Emergency Medicine and has worked at a national level to ensure that trainee doctors get the opportunity to make Paediatric Emergency Medicine their career.
During her time as a Consultant, Tina has seen the specialty grow in size, skill and credibility. In the Emergency Department she is equally at home managing minor illness and injury or in leading the resuscitation of critically ill or injured children. As lead for Major Trauma she has worked with colleagues at a national level to ensure that seriously injured children are assured of the best possible care in our hospitals. She possesses excellent communication skills, both in the clinical setting and in teaching and presenting to large audiences; an essential requirement to be successful in this role.
Expertise: Cardiac surgery
David Barron is the senior cardiac surgeon at Birmingham Children’s Hospital, which is one of the largest programmes for children’s heart surgery in Europe.
The department has an international reputation for management of some of the most complex forms of congenital heart disease and David has been invited to operate on these conditions throughout the UK as well as across Europe and Asia.
Mr Barron has delivered over 200 invited lectures at national and international meetings and was the inaugural chair of the Congenital Heart Surgeons’ Committee of the Society for Cardiothoracic Surgery of Great Britain (SCTS). He has been on the executive of the British Congenital Cardiac Society and the SCTS. He has been the lead for training in congenital cardiac surgery in the UK since 2007 and established it as a formal sub-specialty with the GMC in 2013.
He has been part of the Clinical Advisory Panel to the NHS England review of Congenital Heart Services. Mr Barron has led a programme in Kuala Lumpur to develop their National Heart Hospital in a partnership with Birmingham Children's Hospital since 2008, which has now been awarded as a centre of excellence status in 2016.
Mr Barron was also elected to the Congenital Domain of the European Association for Cardiothoracic Surgery and is an Associate Editor of the European Journal.
Dr Larissa Kerecuk, Rare Disease Lead, Consultant Paediatric Nephrologist, Transition and Research Lead for the Renal Department
Expertise: Kidney Disease (especially rare and genetic renal), Renal transplantation and dialysis, Holistic Care for Rare Diseases and Undiagnosed Genetic Disorders, Transition of Care between children and adult care, Human Factors and Patient Safety
Dr Larissa Kerecuk is the Rare Disease Lead at Birmingham Children’s Hospital and is developing the first Paediatric Rare Disease Centre in the UK for holistic patient care. Larissa also leads the 100,000 Genome Project at Birmingham Children’s Hospital.
As Consultant Paediatric Nephrologist, Larissa specialises in treating children with kidney diseases including those on dialysis, who require a holistic approach.
Larissa has been the Transition Lead for renal patients for six years and runs joint clinics with University Hospital Birmingham to help ease the transition for patients from child to adult services. Larissa is also the Research Lead for the Renal department and believes that every patient is entitled to research that could help improve their care or relieve their condition. We are the top paediatric hospital recruiting to the Renal Radar which is a collaboration of patients, scientists and doctors for rare renal diseases. Larissa is the founder and coordinator of the Autosomal Recessive Polycystic Kidney Disease Rare Disease Group in the UK and has established international collaborations with the US and Europe and published international consensus guidelines. Larissa also developed and teaches a course that aims to improve patient safety.
Larissa is a member of several professional bodies including the Royal College of Paediatrics and Child Health where she is also an Examiner. Larissa is proud to have recently joined the management committee of Rare Disease UK which is the national alliance for people with rare diseases and all who support them.
Michelle McLoughlin, Chief Nursing Officer
Expertise: Paediatric Nursing
Michelle’s background is as a trained adult nurse, sick children’s nurse and district nurse. She first joined Birmingham Children’s Hospital as a Specialist Liaison Nurse in 1991, concentrating on the care and treatment of children with complex needs. In this role, Michelle’s focus was to ensure a prompt discharge into the community and a safe transition of her patients into the hands of the West Midlands community teams.
A few years later, Michelle progressed into a Departmental Manager role before moving into the position of Assistant Director of Nursing.
During her time as Deputy Director of Nursing, Birmingham Children’s Hospital became a Foundation Trust and it was after this change in 2007 that Michelle successfully became the Director of Nursing/Chief Nurse.
Michelle is an experienced Board Director who operates as a system and organisational leader. With extensive healthcare knowledge, she combines her clinical and leadership skills to put women, children, young people and families at the centre of Birmingham Women’s and Children’s NHS Foundation Trust. As an Executive Director, she has a wide and varied portfolio ranging from nursing to facilities.
Her national profile includes being the Chair of the National Association of Chief Children’s Nurses (ACCN) and she is currently the Chair for a national project focusing on safe and sustainable workforce for children and young people’s inpatient hospital care.